Although OM has been developed for heart failure patients, cardiac myosin (Myh7 or β-Myh) is identical to the type I myosin expressed by slow skeletal muscles[21] suggesting that OM might also be effective in skeletal muscle. The gene discussed is MYH7; the disease is heart failure.